Molecular Weight:   | 280.17 |
Volume:   | 295.431 |
LogP:   | 2.087 |
LogD:   | 2.02 |
LogS:   | -3.434 |
# Rotatable Bonds:   | 0 |
TPSA:   | 63.6 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 1 |
# Rings:   | 2 |
# Heavy Atoms:   | 4 |
QED Drug-Likeness Score:   | 0.546 |
Synthetic Accessibility Score:   | 4.526 |
Fsp3:   | 0.75 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Accepted |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.697 |
MDCK Permeability:   | 0.00010739455319708213 |
Pgp-inhibitor:   | 0.805 |
Pgp-substrate:   | 0.752 |
Human Intestinal Absorption (HIA):   | 0.027 |
20% Bioavailability (F20%):   | 0.379 |
30% Bioavailability (F30%):   | 0.987 |
Blood-Brain-Barrier Penetration (BBB):   | 0.966 |
Plasma Protein Binding (PPB):   | 79.67487335205078% |
Volume Distribution (VD):   | 0.358 |
Pgp-substrate:   | 18.845928192138672% |
CYP1A2-inhibitor:   | 0.032 |
CYP1A2-substrate:   | 0.114 |
CYP2C19-inhibitor:   | 0.029 |
CYP2C19-substrate:   | 0.24 |
CYP2C9-inhibitor:   | 0.03 |
CYP2C9-substrate:   | 0.585 |
CYP2D6-inhibitor:   | 0.014 |
CYP2D6-substrate:   | 0.367 |
CYP3A4-inhibitor:   | 0.431 |
CYP3A4-substrate:   | 0.219 |
Clearance (CL):   | 8.965 |
Half-life (T1/2):   | 0.878 |
hERG Blockers:   | 0.027 |
Human Hepatotoxicity (H-HT):   | 0.395 |
Drug-inuced Liver Injury (DILI):   | 0.153 |
AMES Toxicity:   | 0.024 |
Rat Oral Acute Toxicity:   | 0.74 |
Maximum Recommended Daily Dose:   | 0.962 |
Skin Sensitization:   | 0.826 |
Carcinogencity:   | 0.921 |
Eye Corrosion:   | 0.576 |
Eye Irritation:   | 0.247 |
Respiratory Toxicity:   | 0.469 |
Natural Product ID:   | NPC55304 |
Common Name*:   | Brefeldin A |
IUPAC Name:   | (1S,2E,7S,10E,12R,13R,15S)-12,15-dihydroxy-7-methyl-8-oxabicyclo[11.3.0]hexadeca-2,10-dien-9-one |
Synonyms:   | |
Standard InCHIKey:   | KQNZDYYTLMIZCT-KQPMLPITSA-N |
Standard InCHI:   | InChI=1S/C16H24O4/c1-11-5-3-2-4-6-12-9-13(17)10-14(12)15(18)7-8-16(19)20-11/h4,6-8,11-15,17-18H,2-3,5,9-10H2,1H3/b6-4+,8-7+/t11-,12+,13-,14+,15+/m0/s1 |
SMILES:   | C[C@H]1CCC/C=C/[C@@H]2C[C@@H](C[C@H]2[C@@H](/C=C/C(=O)O1)O)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL19980 |
PubChem CID:   |
5287620 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | n.a. | n.a. |
PMID[12444684] |
|
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | n.a. | n.a. |
PMID[16441074] |
|
NPO40682 | Unidentifiable sponge-derived fungus | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. |
PMID[17125221] |
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | Australian | n.a. |
PMID[18288804] |
|
NPO32749 | unidentified soil fungi | Species | n.a. | n.a. | n.a. | Chile | 1998 |
PMID[18327911] |
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | n.a. | n.a. |
PMID[19199645] |
|
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | Mangrove Rhizophora apiculata | n.a. |
PMID[22524636] |
|
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | n.a. | n.a. |
PMID[22524636] |
|
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | n.a. | n.a. |
PMID[25689430] |
|
NPO32963 | Acremonium sp. | Species | Eukaryota | n.a. | n.a. | n.a. |
PMID[26928174] |
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | = | 70.0 | nM | PMID[568199] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | = | 29.0 | nM | PMID[568199] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | = | 40.0 | nM | PMID[568199] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | = | 22.0 | nM | PMID[568199] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | = | 32.0 | nM | PMID[568199] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | = | 90.0 | nM | PMID[568199] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 130.0 | nM | PMID[568199] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | = | 41.0 | nM | PMID[568199] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | = | 70.0 | nM | PMID[568200] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | = | 29.0 | nM | PMID[568200] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | = | 40.0 | nM | PMID[568200] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | = | 22.0 | nM | PMID[568200] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | = | 32.0 | nM | PMID[568200] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | = | 90.0 | nM | PMID[568200] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | = | 130.0 | nM | PMID[568200] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | = | 41.0 | nM | PMID[568200] |
NPT517 | Cell Line | Panel NCI-60 (60 carcinoma cell lines) | Homo sapiens | GI50 | = | 40.0 | nM | PMID[568202] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | = | 20.0 | nM | PMID[568202] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | = | 50.0 | nM | PMID[568202] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | = | 90.0 | nM | PMID[568202] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | = | 30.0 | nM | PMID[568202] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | = | 20.0 | nM | PMID[568202] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | = | 40.0 | nM | PMID[568202] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | = | 30.0 | nM | PMID[568202] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | = | 40.0 | nM | PMID[568202] |
NPT71 | Cell Line | HEK293 | Homo sapiens | Activity | = | 50.0 | % | PMID[568204] |
NPT90 | Cell Line | DU-145 | Homo sapiens | Activity | = | 0.13 | ug ml-1 | PMID[568206] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | Activity | = | 0.041 | ug ml-1 | PMID[568206] |
NPT168 | Cell Line | P388 | Mus musculus | Activity | = | 0.23 | ug ml-1 | PMID[568206] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | Activity | = | 0.28 | ug ml-1 | PMID[568206] |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | Activity | = | 0.022 | ug ml-1 | PMID[568206] |
NPT1081 | Cell Line | BXPC-3 | Homo sapiens | Activity | = | 0.07 | ug ml-1 | PMID[568206] |
NPT83 | Cell Line | MCF7 | Homo sapiens | Activity | = | 0.047 | ug ml-1 | PMID[568206] |
NPT395 | Cell Line | SF-268 | Homo sapiens | Activity | = | 0.21 | ug ml-1 | PMID[568206] |
NPT399 | Cell Line | SF-295 | Homo sapiens | Activity | = | 0.38 | ug ml-1 | PMID[568206] |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | = | 0.0 | Zone units | PMID[568209] |
NPT730 | Cell Line | MC-38 | Mus musculus | Activity | = | 150.0 | Zone units | PMID[568209] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | Activity | = | 0.0 | Zone units | PMID[568209] |
NPT306 | Cell Line | PC-3 | Homo sapiens | FC | = | 0.245 | n.a. | PMID[568211] |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 89.1 | nM | PMID[568215] |
NPT537 | Individual Protein | Ras-related protein Rab-9A | Homo sapiens | Potency | = | 89.1 | nM | PMID[568216] |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | = | 707.9 | nM | PMID[568217] |
NPT3 | Individual Protein | Thioredoxin glutathione reductase | Schistosoma mansoni | Potency | = | 50118.7 | nM | PMID[568216] |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 89.1 | nM | PMID[568215] |
NPT538 | Individual Protein | Niemann-Pick C1 protein | Homo sapiens | Potency | = | 100.0 | nM | PMID[568216] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 16.4 | nM | PMID[568215] |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | n.a. | 231.1 | nM | PMID[568216] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 410.8 | nM | PMID[568215] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 580.2 | nM | PMID[568216] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 7943.3 | nM | PMID[568216] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 1000.0 | nM | PMID[568215] |
NPT64 | Individual Protein | ATPase family AAA domain-containing protein 5 | Homo sapiens | Potency | n.a. | 631.0 | nM | PMID[568216] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 79432.8 | nM | PMID[568215] |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | n.a. | 56234.1 | nM | PMID[568216] |
NPT1397 | Cell Line | INS1 | Rattus norvegicus | AC50 | = | 1029.0 | nM | PMID[568215] |
NPT1397 | Cell Line | INS1 | Rattus norvegicus | AC50 | = | 1065.0 | nM | PMID[568216] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 125.9 | nM | PMID[568216] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 40.64 | nM | PMID[568219] |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | n.a. | 42.36 | nM | PMID[568220] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 29.38 | nM | PMID[568220] |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | n.a. | 84.53 | nM | PMID[568219] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 12.53 | nM | PMID[568220] |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | n.a. | 25.06 | nM | PMID[568219] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 23.17 | nM | PMID[568219] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 35.4 | nM | PMID[568220] |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | n.a. | 104.47 | nM | PMID[568219] |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | n.a. | 18.32 | nM | PMID[568220] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 28.12 | nM | PMID[568220] |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | n.a. | 90.57 | nM | PMID[568219] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 79.98 | nM | PMID[568219] |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | n.a. | 41.69 | nM | PMID[568220] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 21.38 | nM | PMID[568220] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 78.52 | nM | PMID[568220] |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | n.a. | 21.09 | nM | PMID[568219] |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | n.a. | 191.87 | nM | PMID[568219] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 18.11 | nM | PMID[568220] |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | n.a. | 5.834 | nM | PMID[568219] |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | n.a. | 11.35 | nM | PMID[568219] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 36.64 | nM | PMID[568220] |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | n.a. | 71.45 | nM | PMID[568219] |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | n.a. | 17.42 | nM | PMID[568219] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 18.16 | nM | PMID[568220] |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | n.a. | 30.48 | nM | PMID[568219] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 16.52 | nM | PMID[568220] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 21.58 | nM | PMID[568220] |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | n.a. | 72.11 | nM | PMID[568219] |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | n.a. | 48.08 | nM | PMID[568219] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 68.08 | nM | PMID[568219] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 14.89 | nM | PMID[568220] |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | n.a. | 36.73 | nM | PMID[568220] |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | n.a. | 27.42 | nM | PMID[568219] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 12.91 | nM | PMID[568220] |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | n.a. | 22.18 | nM | PMID[568219] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 24.04 | nM | PMID[568220] |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | n.a. | 43.95 | nM | PMID[568219] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 30.83 | nM | PMID[568220] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | n.a. | 133.66 | nM | PMID[568219] |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | n.a. | 26.61 | nM | PMID[568219] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 57.02 | nM | PMID[568219] |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | n.a. | 14.66 | nM | PMID[568220] |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | n.a. | 20.51 | nM | PMID[568219] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 32.73 | nM | PMID[568219] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 36.73 | nM | PMID[568220] |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | n.a. | 40.83 | nM | PMID[568219] |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | n.a. | 17.38 | nM | PMID[568220] |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | n.a. | 1.0 | nM | PMID[568219] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 44.06 | nM | PMID[568220] |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | n.a. | 95.28 | nM | PMID[568219] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 10.05 | nM | PMID[568220] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 16.14 | nM | PMID[568220] |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | n.a. | 26.06 | nM | PMID[568219] |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | n.a. | 10.19 | nM | PMID[568219] |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | n.a. | 6.486 | nM | PMID[568219] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 73.62 | nM | PMID[568219] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 36.39 | nM | PMID[568220] |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | n.a. | 34.51 | nM | PMID[568220] |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | n.a. | 46.24 | nM | PMID[568219] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 13.15 | nM | PMID[568220] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 14.69 | nM | PMID[568220] |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | n.a. | 24.72 | nM | PMID[568219] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 92.9 | nM | PMID[568219] |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | n.a. | 12.27 | nM | PMID[568219] |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 47.42 | nM | PMID[568220] |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | n.a. | 30.62 | nM | PMID[568219] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 20.75 | nM | PMID[568220] |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | n.a. | 4.102 | nM | PMID[568219] |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | n.a. | 43.45 | nM | PMID[568219] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 15.35 | nM | PMID[568220] |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | n.a. | 8.974 | nM | PMID[568219] |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | n.a. | 62.23 | nM | PMID[568219] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 69.18 | nM | PMID[568219] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 18.16 | nM | PMID[568220] |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | n.a. | 43.05 | nM | PMID[568220] |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | n.a. | 23.33 | nM | PMID[568219] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 10.33 | nM | PMID[568220] |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | n.a. | 22.54 | nM | PMID[568219] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 16.41 | nM | PMID[568220] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 26.3 | nM | PMID[568219] |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | n.a. | 54.33 | nM | PMID[568219] |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | n.a. | 16.37 | nM | PMID[568220] |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | n.a. | 8.77 | nM | PMID[568219] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 20.14 | nM | PMID[568220] |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | n.a. | 25.64 | nM | PMID[568219] |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | n.a. | 58.88 | nM | PMID[568219] |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | n.a. | 123.59 | nM | PMID[568219] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 60.12 | nM | PMID[568220] |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | n.a. | 44.06 | nM | PMID[568219] |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | n.a. | 71.45 | nM | PMID[568220] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 36.06 | nM | PMID[568220] |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | n.a. | 83.75 | nM | PMID[568219] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 14.22 | nM | PMID[568220] |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | n.a. | 18.16 | nM | PMID[568219] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 36.31 | nM | PMID[568219] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 22.7 | nM | PMID[568220] |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | n.a. | 54.45 | nM | PMID[568219] |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | n.a. | 17.34 | nM | PMID[568220] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 39.45 | nM | PMID[568220] |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | n.a. | 107.15 | nM | PMID[568219] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 18.11 | nM | PMID[568220] |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | n.a. | 52.36 | nM | PMID[568219] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | n.a. | 10.14 | nM | PMID[568219] |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | n.a. | 100.93 | nM | PMID[568219] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | n.a. | 6.745 | nM | PMID[568219] |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | n.a. | 13.15 | nM | PMID[568219] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 27.48 | nM | PMID[568220] |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | n.a. | 16.03 | nM | PMID[568219] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 18.24 | nM | PMID[568220] |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | n.a. | 13.43 | nM | PMID[568219] |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | n.a. | 50.12 | nM | PMID[568219] |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | n.a. | 19.86 | nM | PMID[568220] |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | n.a. | 25.82 | nM | PMID[568219] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 19.19 | nM | PMID[568219] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 10.0 | nM | PMID[568220] |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | n.a. | 15.85 | nM | PMID[568219] |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | n.a. | 19.91 | nM | PMID[568220] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 14.32 | nM | PMID[568220] |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | n.a. | 16.37 | nM | PMID[568219] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 14.45 | nM | PMID[568220] |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | n.a. | 13.43 | nM | PMID[568219] |
NPT732 | Cell Line | HOP-18 | Homo sapiens | GI50 | n.a. | 2811.9 | nM | PMID[568219] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 651.3 | nM | PMID[568215] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 231.1 | nM | PMID[568216] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 73.1 | nM | PMID[568216] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 326.4 | nM | PMID[568215] |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | n.a. | 1000.0 | nM | PMID[568216] |
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | -3.21 | % | PMID[568222] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 14.6 | nM | PMID[568215] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 651.3 | nM | PMID[568216] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 580.5 | nM | PMID[568216] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 73.1 | nM | PMID[568215] |
NPT585 | Individual Protein | Nuclear receptor subfamily 0 group B member 1 | Homo sapiens | IC50 | = | 134.26 | nM | PMID[568215] |
NPT1283 | Individual Protein | Paired box protein Pax-8 | Homo sapiens | AC50 | < | 260.0 | nM | PMID[568216] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 16360.1 | nM | PMID[568215] |
NPT444 | Individual Protein | Ubiquitin carboxyl-terminal hydrolase 1 | Homo sapiens | Potency | n.a. | 6309.6 | nM | PMID[568216] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 11582.1 | nM | PMID[568216] |
NPT2852 | Individual Protein | Prion protein | Homo sapiens | IC50 | = | 3505.0 | nM | PMID[568216] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 58.0 | nM | PMID[568215] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 115.8 | nM | PMID[568216] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 73.1 | nM | PMID[568215] |
NPT154 | Individual Protein | Mothers against decapentaplegic homolog 3 | Homo sapiens | Potency | n.a. | 326.4 | nM | PMID[568216] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | FC | = | 0.96 | n.a. | PMID[568224] |
NPT282 | Individual Protein | MAP kinase ERK2 | Homo sapiens | FC | = | 0.97 | n.a. | PMID[568224] |
NPT281 | Individual Protein | MAP kinase ERK1 | Homo sapiens | FC | = | 0.99 | n.a. | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | FC | = | 0.99 | n.a. | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 38.8 | % | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 79.3 | % | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 48.4 | % | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 83.4 | % | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 51.2 | % | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | Activity | = | 18.0 | % | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | FC | = | 0.32 | n.a. | PMID[568224] |
NPT281 | Individual Protein | MAP kinase ERK1 | Homo sapiens | FC | = | 0.93 | n.a. | PMID[568224] |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 68.0 | nM | PMID[568225] |
NPT139 | Cell Line | HT-29 | Homo sapiens | IC50 | = | 160.0 | nM | PMID[568225] |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 350.0 | nM | PMID[568225] |
NPT116 | Cell Line | HL-60 | Homo sapiens | IC50 | = | 25.0 | nM | PMID[568226] |
NPT306 | Cell Line | PC-3 | Homo sapiens | IC50 | = | 68.0 | nM | PMID[568226] |
NPT181 | Cell Line | Bel-7402 | Homo sapiens | IC50 | = | 24.0 | nM | PMID[568226] |
NPT605 | Organism | Homo sapiens | Homo sapiens | MGM | = | 0.04 | uM | PMID[568199] |
NPT636 | Organism | Phytophthora capsici | Phytophthora capsici | Activity | = | 50.0 | ug disk-1 | PMID[568201] |
NPT2 | Others | Unspecified | Inhibition | = | 0.0 | % | PMID[568201] | |
NPT2 | Others | Unspecified | Inhibition | = | 6.0 | % | PMID[568201] | |
NPT614 | Tissue | Plasma | Rattus norvegicus | T1/2 | > | 24.0 | hr | PMID[568202] |
NPT1173 | Organism | Candida albicans SC5314 | Candida albicans SC5314 | MIC | = | 4.0 | ug.mL-1 | PMID[568203] |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 16.0 | ug.mL-1 | PMID[568203] |
NPT1173 | Organism | Candida albicans SC5314 | Candida albicans SC5314 | MIC | = | 8.0 | ug.mL-1 | PMID[568203] |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 32.0 | ug.mL-1 | PMID[568203] |
NPT2 | Others | Unspecified | Ki | = | 15000.0 | nM | PMID[568205] | |
NPT2 | Others | Unspecified | Kd | = | 8600.0 | nM | PMID[568205] | |
NPT141 | Organism | Agrobacterium tumefaciens | Agrobacterium tumefaciens | Activity | = | -62.0 | % | PMID[568207] |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | LD50 | = | 275.0 | mg.kg-1 | PMID[568208] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 900.0 | Zone units | PMID[568209] |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | Activity | = | 600.0 | Zone units | PMID[568209] |
NPT27 | Others | Unspecified | Activity | = | 1000.0 | Zone units | PMID[568209] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 1995.26 | nM | PMID[568214] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 3162.28 | nM | PMID[568214] |
NPT1173 | Organism | Candida albicans SC5314 | Candida albicans SC5314 | MIC | = | 1.56 | ug.mL-1 | PMID[568218] |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 1.56 | ug.mL-1 | PMID[568218] |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 25.0 | ug.mL-1 | PMID[568218] |
NPT2580 | Organism | Candida dubliniensis | Candida dubliniensis | MIC | = | 1.56 | ug.mL-1 | PMID[568218] |
NPT2580 | Organism | Candida dubliniensis | Candida dubliniensis | MIC | = | 12.5 | ug.mL-1 | PMID[568218] |
NPT2580 | Organism | Candida dubliniensis | Candida dubliniensis | MIC | = | 3.13 | ug.mL-1 | PMID[568218] |
NPT2 | Others | Unspecified | AC50 | < | 160.0 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | AC50 | < | 160.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | Potency | n.a. | 23.1 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | IC50 | > | 80000.0 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | Potency | n.a. | 145.8 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | IC50 | > | 80000.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | IC50 | = | 420.0 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | IC50 | = | 520.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | IC50 | = | 63600.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | Potency | n.a. | 231.1 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | Potency | n.a. | 580.5 | nM | PMID[568216] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2332.3 | nM | PMID[568215] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2936.2 | nM | PMID[568216] |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | n.a. | 56234.1 | nM | PMID[568215] |
NPT2 | Others | Unspecified | Potency | n.a. | 446.7 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | Potency | n.a. | 631.0 | nM | PMID[568216] | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2616.9 | nM | PMID[568215] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 2078.7 | nM | PMID[568216] |
NPT2 | Others | Unspecified | AC50 | = | 3150.0 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | AC50 | = | 2200.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | AC50 | = | 10290.0 | nM | PMID[568216] | |
NPT20 | Organism | Candida albicans | Candida albicans | MIC | = | 32.0 | ug.mL-1 | PMID[568221] |
NPT2 | Others | Unspecified | Potency | n.a. | 891.3 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | Potency | n.a. | 562.3 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | Potency | n.a. | 35481.3 | nM | PMID[568215] | |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 5.24 | % | PMID[568222] |
NPT2 | Others | Unspecified | Potency | n.a. | 18.4 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | Potency | n.a. | 6.5 | nM | PMID[568216] | |
NPT35 | Others | n.a. | IC50 | > | 67602.0 | nM | PMID[568215] | |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 58.0 | nM | PMID[568215] |
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | n.a. | 410.9 | nM | PMID[568216] |
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | > | 200.0 | mg.kg-1 | PMID[568223] |
NPT2 | Others | Unspecified | LC50 | = | 52600.0 | nM | PMID[568223] | |
NPT2 | Others | Unspecified | TGI | = | 3480.0 | nM | PMID[568223] | |
NPT2 | Others | Unspecified | GI50 | = | 20.6 | nM | PMID[568223] | |
NPT2 | Others | Unspecified | Potency | n.a. | 2818.4 | nM | PMID[568215] | |
NPT2 | Others | Unspecified | Potency | n.a. | 1778.3 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | Potency | n.a. | 92.0 | nM | PMID[568215] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | IC50 | > | 138122.0 | nM | PMID[568216] |
NPT2 | Others | Unspecified | Potency | n.a. | 1122.0 | nM | PMID[568217] | |
NPT20529 | NON-MOLECULAR | NON-PROTEIN TARGET | n.a. | AbsAC35_uM | = | 0.115 | uM | PMID[568216] |
NPT2 | Others | Unspecified | Potency | n.a. | 1000.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | Potency | n.a. | 206.0 | nM | PMID[568216] | |
NPT2 | Others | Unspecified | AbsAC35_uM | = | 15.17 | uM | PMID[568216] | |
NPT728 | Individual Protein | Serine/threonine-protein kinase AKT | Homo sapiens | FC | = | 0.99 | n.a. | PMID[568224] |
NPT624 | Tissue | Plasma | Mus musculus | Cp | = | 700.0 | nM | PMID[568224] |
NPT2 | Others | Unspecified | Selectivity ratio | = | 4.0 | n.a. | PMID[568224] | |
NPT728 | Individual Protein | Serine/threonine-protein kinase AKT | Homo sapiens | FC | = | 0.97 | n.a. | PMID[568224] |
NPT21742 | CELL-LINE | L02 | Homo sapiens | IC50 | < | 0.4 | nM | PMID[568225] |
NPT23193 | CELL-LINE | Bel7402/5-FU | Homo sapiens | IC50 | = | 820.0 | nM | PMID[568226] |
NPT21742 | CELL-LINE | L02 | Homo sapiens | IC50 | < | 1.0 | nM | PMID[568226] |
NPT19 | Organism | Escherichia coli | Escherichia coli | Inhibition | = | 11.85 | % | PMID[568227] |
NPT18 | Organism | Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | = | 10.94 | % | PMID[568227] |
NPT20 | Organism | Candida albicans | Candida albicans | Inhibition | = | 51.33 | % | PMID[568227] |
NPT85 | Organism | Filobasidiella neoformans | Cryptococcus neoformans | Inhibition | = | -9.22 | % | PMID[568227] |
NPT747 | Organism | Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | = | -7.42 | % | PMID[568227] |
NPT2922 | Organism | Staphylococcus aureus subsp. aureus | Staphylococcus aureus subsp. aureus | Inhibition | = | 11.17 | % | PMID[568227] |
NPT173 | Organism | Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | = | -5.16 | % | PMID[568227] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 11.4 | % | PMID[568228] |
NPT5239 | Organism | Dengue virus 1 | Dengue virus 1 | EC50 | = | 54600.0 | nM | PMID[568230] |
NPT194 | Organism | Dengue virus 2 | Dengue virus 2 | EC50 | = | 54600.0 | nM | PMID[568230] |
NPT5238 | Organism | Dengue virus 3 | Dengue virus 3 | EC50 | = | 54600.0 | nM | PMID[568230] |
NPT4328 | Organism | Dengue virus type 4 | Dengue virus 4 | EC50 | = | 54600.0 | nM | PMID[568230] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 12.23 | % | PMID[568231] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 24.08 | % | PMID[568232] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 6.1 | % | PMID[568233] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 1.21 | % | PMID[568234] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | = | 20.0 | nM | PMID[568233] |
NPT22224 | CELL-LINE | Vero C1008 | Chlorocebus sabaeus | CC50 | = | 60.0 | nM | PMID[568233] |
NPT27 | Others | Unspecified | Selectivity index | = | 3.0 | n.a. | PMID[568233] | |
NPT2 | Others | Unspecified | EC50 | = | 5000.0 | nM | PMID[568235] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC55304 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC226226 |
0.8272 | Intermediate Similarity | NPC315731 |
0.825 | Intermediate Similarity | NPC139712 |
0.8228 | Intermediate Similarity | NPC476439 |
0.8182 | Intermediate Similarity | NPC477085 |
0.8101 | Intermediate Similarity | NPC469880 |
0.8052 | Intermediate Similarity | NPC477087 |
0.8052 | Intermediate Similarity | NPC477086 |
0.8049 | Intermediate Similarity | NPC184208 |
0.8049 | Intermediate Similarity | NPC8538 |
0.8046 | Intermediate Similarity | NPC473448 |
0.8025 | Intermediate Similarity | NPC86971 |
0.7949 | Intermediate Similarity | NPC329890 |
0.7922 | Intermediate Similarity | NPC4299 |
0.7907 | Intermediate Similarity | NPC316629 |
0.7901 | Intermediate Similarity | NPC323249 |
0.7901 | Intermediate Similarity | NPC27949 |
0.7901 | Intermediate Similarity | NPC260814 |
0.7901 | Intermediate Similarity | NPC39547 |
0.7857 | Intermediate Similarity | NPC116543 |
0.7831 | Intermediate Similarity | NPC112868 |
0.7821 | Intermediate Similarity | NPC319163 |
0.7821 | Intermediate Similarity | NPC67076 |
0.7808 | Intermediate Similarity | NPC26810 |
0.7792 | Intermediate Similarity | NPC101622 |
0.7791 | Intermediate Similarity | NPC311163 |
0.7778 | Intermediate Similarity | NPC84360 |
0.7778 | Intermediate Similarity | NPC233071 |
0.7753 | Intermediate Similarity | NPC475925 |
0.7727 | Intermediate Similarity | NPC133450 |
0.7722 | Intermediate Similarity | NPC327383 |
0.7722 | Intermediate Similarity | NPC185186 |
0.7722 | Intermediate Similarity | NPC329914 |
0.7701 | Intermediate Similarity | NPC313658 |
0.7701 | Intermediate Similarity | NPC471796 |
0.7701 | Intermediate Similarity | NPC316138 |
0.7692 | Intermediate Similarity | NPC304886 |
0.7692 | Intermediate Similarity | NPC476037 |
0.7683 | Intermediate Similarity | NPC192006 |
0.7683 | Intermediate Similarity | NPC248775 |
0.7683 | Intermediate Similarity | NPC93763 |
0.7683 | Intermediate Similarity | NPC108816 |
0.7674 | Intermediate Similarity | NPC471494 |
0.766 | Intermediate Similarity | NPC150923 |
0.7654 | Intermediate Similarity | NPC279537 |
0.7654 | Intermediate Similarity | NPC477202 |
0.7654 | Intermediate Similarity | NPC188860 |
0.7647 | Intermediate Similarity | NPC40746 |
0.7647 | Intermediate Similarity | NPC477667 |
0.7647 | Intermediate Similarity | NPC169575 |
0.764 | Intermediate Similarity | NPC177668 |
0.764 | Intermediate Similarity | NPC3952 |
0.764 | Intermediate Similarity | NPC475855 |
0.7625 | Intermediate Similarity | NPC470686 |
0.7619 | Intermediate Similarity | NPC191711 |
0.7619 | Intermediate Similarity | NPC316844 |
0.7619 | Intermediate Similarity | NPC88735 |
0.7619 | Intermediate Similarity | NPC325031 |
0.7595 | Intermediate Similarity | NPC472254 |
0.7595 | Intermediate Similarity | NPC316185 |
0.759 | Intermediate Similarity | NPC1180 |
0.759 | Intermediate Similarity | NPC470149 |
0.759 | Intermediate Similarity | NPC201225 |
0.759 | Intermediate Similarity | NPC470148 |
0.759 | Intermediate Similarity | NPC180725 |
0.7586 | Intermediate Similarity | NPC305475 |
0.7586 | Intermediate Similarity | NPC475461 |
0.7586 | Intermediate Similarity | NPC477668 |
0.7582 | Intermediate Similarity | NPC469491 |
0.7582 | Intermediate Similarity | NPC472467 |
0.7564 | Intermediate Similarity | NPC151481 |
0.7561 | Intermediate Similarity | NPC474026 |
0.7561 | Intermediate Similarity | NPC477203 |
0.7561 | Intermediate Similarity | NPC116177 |
0.7561 | Intermediate Similarity | NPC315394 |
0.7561 | Intermediate Similarity | NPC7563 |
0.7561 | Intermediate Similarity | NPC320630 |
0.7561 | Intermediate Similarity | NPC475711 |
0.7558 | Intermediate Similarity | NPC154893 |
0.7558 | Intermediate Similarity | NPC16887 |
0.7558 | Intermediate Similarity | NPC53011 |
0.7558 | Intermediate Similarity | NPC160517 |
0.7558 | Intermediate Similarity | NPC186155 |
0.7558 | Intermediate Similarity | NPC78673 |
0.7558 | Intermediate Similarity | NPC37005 |
0.7558 | Intermediate Similarity | NPC476804 |
0.7553 | Intermediate Similarity | NPC79631 |
0.7532 | Intermediate Similarity | NPC472266 |
0.7531 | Intermediate Similarity | NPC68624 |
0.7531 | Intermediate Similarity | NPC327041 |
0.7531 | Intermediate Similarity | NPC285840 |
0.7531 | Intermediate Similarity | NPC329852 |
0.7529 | Intermediate Similarity | NPC224455 |
0.7528 | Intermediate Similarity | NPC295312 |
0.7527 | Intermediate Similarity | NPC161493 |
0.7527 | Intermediate Similarity | NPC477949 |
0.75 | Intermediate Similarity | NPC45957 |
0.75 | Intermediate Similarity | NPC220221 |
0.75 | Intermediate Similarity | NPC160138 |
0.75 | Intermediate Similarity | NPC470147 |
0.75 | Intermediate Similarity | NPC471657 |
0.75 | Intermediate Similarity | NPC67584 |
0.75 | Intermediate Similarity | NPC199382 |
0.75 | Intermediate Similarity | NPC213698 |
0.75 | Intermediate Similarity | NPC170120 |
0.75 | Intermediate Similarity | NPC133226 |
0.75 | Intermediate Similarity | NPC52044 |
0.7473 | Intermediate Similarity | NPC295204 |
0.7473 | Intermediate Similarity | NPC475838 |
0.7473 | Intermediate Similarity | NPC162205 |
0.7473 | Intermediate Similarity | NPC228451 |
0.7473 | Intermediate Similarity | NPC125674 |
0.7473 | Intermediate Similarity | NPC476049 |
0.7473 | Intermediate Similarity | NPC273579 |
0.7473 | Intermediate Similarity | NPC288240 |
0.7471 | Intermediate Similarity | NPC470755 |
0.7471 | Intermediate Similarity | NPC255307 |
0.7471 | Intermediate Similarity | NPC471795 |
0.7471 | Intermediate Similarity | NPC146850 |
0.7471 | Intermediate Similarity | NPC261380 |
0.7471 | Intermediate Similarity | NPC287015 |
0.7471 | Intermediate Similarity | NPC21469 |
0.747 | Intermediate Similarity | NPC172066 |
0.747 | Intermediate Similarity | NPC267231 |
0.7468 | Intermediate Similarity | NPC476012 |
0.7447 | Intermediate Similarity | NPC65700 |
0.7444 | Intermediate Similarity | NPC472466 |
0.7444 | Intermediate Similarity | NPC179394 |
0.7444 | Intermediate Similarity | NPC144133 |
0.7442 | Intermediate Similarity | NPC44261 |
0.7442 | Intermediate Similarity | NPC473390 |
0.7442 | Intermediate Similarity | NPC250315 |
0.7442 | Intermediate Similarity | NPC311070 |
0.7442 | Intermediate Similarity | NPC474809 |
0.7442 | Intermediate Similarity | NPC231601 |
0.7442 | Intermediate Similarity | NPC472473 |
0.7442 | Intermediate Similarity | NPC131669 |
0.7439 | Intermediate Similarity | NPC476317 |
0.7419 | Intermediate Similarity | NPC213078 |
0.7419 | Intermediate Similarity | NPC24956 |
0.7419 | Intermediate Similarity | NPC18019 |
0.7416 | Intermediate Similarity | NPC476805 |
0.7416 | Intermediate Similarity | NPC207114 |
0.7416 | Intermediate Similarity | NPC475819 |
0.7416 | Intermediate Similarity | NPC217983 |
0.7412 | Intermediate Similarity | NPC475944 |
0.7412 | Intermediate Similarity | NPC47031 |
0.7412 | Intermediate Similarity | NPC24417 |
0.7407 | Intermediate Similarity | NPC474280 |
0.7407 | Intermediate Similarity | NPC315843 |
0.7391 | Intermediate Similarity | NPC474247 |
0.7391 | Intermediate Similarity | NPC470013 |
0.7391 | Intermediate Similarity | NPC262133 |
0.7391 | Intermediate Similarity | NPC90453 |
0.7391 | Intermediate Similarity | NPC127019 |
0.7391 | Intermediate Similarity | NPC323008 |
0.7391 | Intermediate Similarity | NPC57117 |
0.7391 | Intermediate Similarity | NPC256368 |
0.7391 | Intermediate Similarity | NPC477131 |
0.7391 | Intermediate Similarity | NPC470010 |
0.7391 | Intermediate Similarity | NPC198853 |
0.7386 | Intermediate Similarity | NPC122502 |
0.7386 | Intermediate Similarity | NPC61527 |
0.7386 | Intermediate Similarity | NPC64153 |
0.7381 | Intermediate Similarity | NPC321728 |
0.7381 | Intermediate Similarity | NPC164308 |
0.7381 | Intermediate Similarity | NPC477088 |
0.7368 | Intermediate Similarity | NPC251680 |
0.7363 | Intermediate Similarity | NPC473321 |
0.7363 | Intermediate Similarity | NPC221282 |
0.7363 | Intermediate Similarity | NPC158061 |
0.7363 | Intermediate Similarity | NPC472468 |
0.7356 | Intermediate Similarity | NPC82297 |
0.7356 | Intermediate Similarity | NPC472958 |
0.7356 | Intermediate Similarity | NPC114979 |
0.7356 | Intermediate Similarity | NPC96259 |
0.7356 | Intermediate Similarity | NPC266718 |
0.7356 | Intermediate Similarity | NPC191476 |
0.7356 | Intermediate Similarity | NPC158756 |
0.7356 | Intermediate Similarity | NPC472957 |
0.7356 | Intermediate Similarity | NPC141193 |
0.7349 | Intermediate Similarity | NPC474278 |
0.7342 | Intermediate Similarity | NPC475004 |
0.734 | Intermediate Similarity | NPC472290 |
0.7333 | Intermediate Similarity | NPC268298 |
0.7333 | Intermediate Similarity | NPC212598 |
0.7333 | Intermediate Similarity | NPC474032 |
0.7326 | Intermediate Similarity | NPC7414 |
0.7326 | Intermediate Similarity | NPC85772 |
0.7326 | Intermediate Similarity | NPC229825 |
0.7326 | Intermediate Similarity | NPC471298 |
0.7326 | Intermediate Similarity | NPC474252 |
0.732 | Intermediate Similarity | NPC183570 |
0.7317 | Intermediate Similarity | NPC113639 |
0.7312 | Intermediate Similarity | NPC272050 |
0.7303 | Intermediate Similarity | NPC191283 |
0.7294 | Intermediate Similarity | NPC115418 |
0.7283 | Intermediate Similarity | NPC472196 |
0.7283 | Intermediate Similarity | NPC472195 |
0.7283 | Intermediate Similarity | NPC238090 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC55304 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8148 | Intermediate Similarity | NPD5790 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD4249 | Approved |
0.7907 | Intermediate Similarity | NPD4251 | Approved |
0.7907 | Intermediate Similarity | NPD4250 | Approved |
0.7901 | Intermediate Similarity | NPD4268 | Approved |
0.7901 | Intermediate Similarity | NPD4271 | Approved |
0.7841 | Intermediate Similarity | NPD5785 | Approved |
0.7711 | Intermediate Similarity | NPD4821 | Approved |
0.7711 | Intermediate Similarity | NPD4820 | Approved |
0.7711 | Intermediate Similarity | NPD4822 | Approved |
0.7711 | Intermediate Similarity | NPD4819 | Approved |
0.7674 | Intermediate Similarity | NPD6082 | Clinical (unspecified phase) |
0.7674 | Intermediate Similarity | NPD5363 | Approved |
0.7444 | Intermediate Similarity | NPD7838 | Discovery |
0.7442 | Intermediate Similarity | NPD5362 | Discontinued |
0.7368 | Intermediate Similarity | NPD7640 | Approved |
0.7368 | Intermediate Similarity | NPD7639 | Approved |
0.7326 | Intermediate Similarity | NPD4269 | Approved |
0.7326 | Intermediate Similarity | NPD6435 | Approved |
0.7326 | Intermediate Similarity | NPD4270 | Approved |
0.7294 | Intermediate Similarity | NPD4252 | Approved |
0.7263 | Intermediate Similarity | NPD7638 | Approved |
0.7262 | Intermediate Similarity | NPD5784 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD7154 | Phase 3 |
0.7241 | Intermediate Similarity | NPD5332 | Approved |
0.7241 | Intermediate Similarity | NPD5331 | Approved |
0.7209 | Intermediate Similarity | NPD4790 | Discontinued |
0.7191 | Intermediate Similarity | NPD5786 | Approved |
0.7113 | Intermediate Similarity | NPD5344 | Discontinued |
0.7093 | Intermediate Similarity | NPD5368 | Approved |
0.7083 | Intermediate Similarity | NPD8029 | Clinical (unspecified phase) |
0.7065 | Intermediate Similarity | NPD46 | Approved |
0.7065 | Intermediate Similarity | NPD6698 | Approved |
0.7053 | Intermediate Similarity | NPD4792 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD2685 | Clinical (unspecified phase) |
0.7011 | Intermediate Similarity | NPD5369 | Approved |
0.6989 | Remote Similarity | NPD7637 | Suspended |
0.6932 | Remote Similarity | NPD5209 | Approved |
0.6837 | Remote Similarity | NPD6648 | Approved |
0.6778 | Remote Similarity | NPD6400 | Clinical (unspecified phase) |
0.6771 | Remote Similarity | NPD1698 | Clinical (unspecified phase) |
0.6765 | Remote Similarity | NPD7899 | Clinical (unspecified phase) |
0.6735 | Remote Similarity | NPD4225 | Approved |
0.6731 | Remote Similarity | NPD6371 | Approved |
0.67 | Remote Similarity | NPD7632 | Discontinued |
0.6632 | Remote Similarity | NPD7983 | Approved |
0.6604 | Remote Similarity | NPD6053 | Discontinued |
0.6596 | Remote Similarity | NPD1695 | Approved |
0.6593 | Remote Similarity | NPD7338 | Clinical (unspecified phase) |
0.6562 | Remote Similarity | NPD5778 | Approved |
0.6562 | Remote Similarity | NPD5779 | Approved |
0.6556 | Remote Similarity | NPD4752 | Clinical (unspecified phase) |
0.6538 | Remote Similarity | NPD6686 | Approved |
0.6484 | Remote Similarity | NPD6695 | Phase 3 |
0.6429 | Remote Similarity | NPD7503 | Approved |
0.6421 | Remote Similarity | NPD6051 | Approved |
0.6421 | Remote Similarity | NPD5370 | Suspended |
0.6344 | Remote Similarity | NPD1694 | Approved |
0.6333 | Remote Similarity | NPD7514 | Phase 3 |
0.6329 | Remote Similarity | NPD4246 | Clinical (unspecified phase) |
0.6311 | Remote Similarity | NPD6647 | Phase 2 |
0.6306 | Remote Similarity | NPD7328 | Approved |
0.6306 | Remote Similarity | NPD7327 | Approved |
0.6292 | Remote Similarity | NPD7145 | Approved |
0.6289 | Remote Similarity | NPD4810 | Clinical (unspecified phase) |
0.6286 | Remote Similarity | NPD5697 | Approved |
0.6265 | Remote Similarity | NPD4247 | Clinical (unspecified phase) |
0.6264 | Remote Similarity | NPD6902 | Approved |
0.625 | Remote Similarity | NPD7516 | Approved |
0.625 | Remote Similarity | NPD368 | Approved |
0.6237 | Remote Similarity | NPD5766 | Clinical (unspecified phase) |
0.6226 | Remote Similarity | NPD6011 | Approved |
0.6226 | Remote Similarity | NPD6881 | Approved |
0.6226 | Remote Similarity | NPD6899 | Approved |
0.6222 | Remote Similarity | NPD6929 | Approved |
0.6216 | Remote Similarity | NPD7115 | Discovery |
0.6211 | Remote Similarity | NPD7524 | Approved |
0.6211 | Remote Similarity | NPD7750 | Discontinued |
0.62 | Remote Similarity | NPD7839 | Suspended |
0.6195 | Remote Similarity | NPD8377 | Approved |
0.6195 | Remote Similarity | NPD8294 | Approved |
0.618 | Remote Similarity | NPD6925 | Approved |
0.618 | Remote Similarity | NPD5776 | Phase 2 |
0.617 | Remote Similarity | NPD1733 | Clinical (unspecified phase) |
0.6168 | Remote Similarity | NPD6014 | Approved |
0.6168 | Remote Similarity | NPD6012 | Approved |
0.6168 | Remote Similarity | NPD6013 | Approved |
0.6154 | Remote Similarity | NPD6931 | Approved |
0.6154 | Remote Similarity | NPD6930 | Phase 2 |
0.6154 | Remote Similarity | NPD7332 | Phase 2 |
0.614 | Remote Similarity | NPD8335 | Approved |
0.614 | Remote Similarity | NPD8378 | Approved |
0.614 | Remote Similarity | NPD8379 | Approved |
0.614 | Remote Similarity | NPD8033 | Approved |
0.614 | Remote Similarity | NPD8296 | Approved |
0.614 | Remote Similarity | NPD8380 | Approved |
0.6139 | Remote Similarity | NPD6083 | Phase 2 |
0.6139 | Remote Similarity | NPD6084 | Phase 2 |
0.6132 | Remote Similarity | NPD6685 | Approved |
0.6129 | Remote Similarity | NPD6110 | Phase 1 |
0.6111 | Remote Similarity | NPD6883 | Approved |
0.6111 | Remote Similarity | NPD7290 | Approved |
0.6111 | Remote Similarity | NPD7102 | Approved |
0.6105 | Remote Similarity | NPD7146 | Approved |
0.6105 | Remote Similarity | NPD7521 | Approved |
0.6105 | Remote Similarity | NPD6409 | Approved |
0.6105 | Remote Similarity | NPD6684 | Approved |
0.6105 | Remote Similarity | NPD5330 | Approved |
0.6105 | Remote Similarity | NPD7334 | Approved |
0.61 | Remote Similarity | NPD5695 | Phase 3 |
0.6091 | Remote Similarity | NPD4632 | Approved |
0.6064 | Remote Similarity | NPD3133 | Approved |
0.6064 | Remote Similarity | NPD3665 | Phase 1 |
0.6064 | Remote Similarity | NPD3666 | Approved |
0.6061 | Remote Similarity | NPD6399 | Phase 3 |
0.6058 | Remote Similarity | NPD5211 | Phase 2 |
0.6055 | Remote Similarity | NPD6847 | Approved |
0.6055 | Remote Similarity | NPD6649 | Approved |
0.6055 | Remote Similarity | NPD6869 | Approved |
0.6055 | Remote Similarity | NPD6650 | Approved |
0.6055 | Remote Similarity | NPD8130 | Phase 1 |
0.6055 | Remote Similarity | NPD6617 | Approved |
0.6055 | Remote Similarity | NPD8413 | Clinical (unspecified phase) |
0.6044 | Remote Similarity | NPD4195 | Approved |
0.6042 | Remote Similarity | NPD4751 | Clinical (unspecified phase) |
0.6038 | Remote Similarity | NPD6402 | Approved |
0.6038 | Remote Similarity | NPD4211 | Phase 1 |
0.6038 | Remote Similarity | NPD5739 | Approved |
0.6038 | Remote Similarity | NPD7128 | Approved |
0.6038 | Remote Similarity | NPD6675 | Approved |
0.6 | Remote Similarity | NPD4756 | Discovery |
0.6 | Remote Similarity | NPD6932 | Approved |
0.6 | Remote Similarity | NPD5738 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD5282 | Discontinued |
0.6 | Remote Similarity | NPD6882 | Approved |
0.6 | Remote Similarity | NPD8297 | Approved |
0.5981 | Remote Similarity | NPD6412 | Phase 2 |
0.5981 | Remote Similarity | NPD5701 | Approved |
0.5979 | Remote Similarity | NPD6903 | Approved |
0.5979 | Remote Similarity | NPD7513 | Clinical (unspecified phase) |
0.596 | Remote Similarity | NPD5693 | Phase 1 |
0.596 | Remote Similarity | NPD7087 | Discontinued |
0.596 | Remote Similarity | NPD5284 | Approved |
0.596 | Remote Similarity | NPD5281 | Approved |
0.5955 | Remote Similarity | NPD8039 | Approved |
0.5943 | Remote Similarity | NPD5141 | Approved |
0.5934 | Remote Similarity | NPD7322 | Clinical (unspecified phase) |
0.5932 | Remote Similarity | NPD7507 | Approved |
0.5929 | Remote Similarity | NPD6009 | Approved |
0.5926 | Remote Similarity | NPD7320 | Approved |
0.5922 | Remote Similarity | NPD5696 | Approved |
0.5918 | Remote Similarity | NPD5764 | Clinical (unspecified phase) |
0.5918 | Remote Similarity | NPD6101 | Approved |
0.5913 | Remote Similarity | NPD6319 | Approved |
0.5904 | Remote Similarity | NPD3197 | Phase 1 |
0.5904 | Remote Similarity | NPD5325 | Clinical (unspecified phase) |
0.5897 | Remote Similarity | NPD342 | Phase 1 |
0.5889 | Remote Similarity | NPD3701 | Clinical (unspecified phase) |
0.5872 | Remote Similarity | NPD4061 | Clinical (unspecified phase) |
0.5872 | Remote Similarity | NPD6372 | Approved |
0.5872 | Remote Similarity | NPD6373 | Approved |
0.5865 | Remote Similarity | NPD5286 | Approved |
0.5865 | Remote Similarity | NPD4696 | Approved |
0.5865 | Remote Similarity | NPD5285 | Approved |
0.5862 | Remote Similarity | NPD7143 | Approved |
0.5862 | Remote Similarity | NPD7144 | Approved |
0.5862 | Remote Similarity | NPD5983 | Phase 2 |
0.5854 | Remote Similarity | NPD4194 | Approved |
0.5854 | Remote Similarity | NPD4192 | Approved |
0.5854 | Remote Similarity | NPD4191 | Approved |
0.5854 | Remote Similarity | NPD4193 | Approved |
0.5849 | Remote Similarity | NPD5765 | Approved |
0.5843 | Remote Similarity | NPD6924 | Approved |
0.5843 | Remote Similarity | NPD6926 | Approved |
0.5833 | Remote Similarity | NPD6893 | Approved |
0.5818 | Remote Similarity | NPD6420 | Discontinued |
0.5816 | Remote Similarity | NPD5737 | Approved |
0.5816 | Remote Similarity | NPD6672 | Approved |
0.581 | Remote Similarity | NPD5223 | Approved |
0.5806 | Remote Similarity | NPD7525 | Registered |
0.5802 | Remote Similarity | NPD3198 | Approved |
0.58 | Remote Similarity | NPD6411 | Approved |
0.58 | Remote Similarity | NPD6079 | Approved |
0.5795 | Remote Similarity | NPD7151 | Approved |
0.5795 | Remote Similarity | NPD7150 | Approved |
0.5795 | Remote Similarity | NPD7152 | Approved |
0.5789 | Remote Similarity | NPD6317 | Approved |
0.5789 | Remote Similarity | NPD7505 | Discontinued |
0.5785 | Remote Similarity | NPD7319 | Approved |
0.5784 | Remote Similarity | NPD4629 | Approved |
0.5784 | Remote Similarity | NPD5210 | Approved |
0.5778 | Remote Similarity | NPD8264 | Approved |
0.5773 | Remote Similarity | NPD3618 | Phase 1 |
0.5773 | Remote Similarity | NPD5279 | Phase 3 |
0.5766 | Remote Similarity | NPD6401 | Clinical (unspecified phase) |
0.5763 | Remote Similarity | NPD7604 | Phase 2 |
0.5758 | Remote Similarity | NPD4753 | Phase 2 |
0.5755 | Remote Similarity | NPD5226 | Approved |
0.5755 | Remote Similarity | NPD4633 | Approved |
0.5755 | Remote Similarity | NPD5224 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.